Gerzanich V - Search Results

1

A Mouse Model of Temporal Lobe Contusion.

Simard JM, Tosun C, Tsymbalyuk O, Moyer M, Keledjian K, Tsymbalyuk N, Olaniran A, Evans M, Langbein J, Khan Z, Kreinbrink M, Ciryam P, Stokum JA, Jha RM, Ksendzovsky A, Gerzanich V. Simard JM, et al. Among authors: gerzanich v. J Neurotrauma. 2024 Oct 14. doi: 10.1089/neu.2024.0242. Online ahead of print. J Neurotrauma. 2024. PMID: 39302058

2

Activation of (Na+ + K+)-ATPase modulates cardiac L-type Ca2+ channel function.

Lee DI, Klein MG, Zhu W, Xiao RP, Gerzanich V, Xu KY. Lee DI, et al. Among authors: gerzanich v. Mol Pharmacol. 2009 Apr;75(4):774-81. doi: 10.1124/mol.108.052597. Epub 2009 Jan 2. Mol Pharmacol. 2009. PMID: 19122004 Free PMC article.

3

Functional properties of human nicotinic AChRs expressed by IMR-32 neuroblastoma cells resemble those of alpha3beta4 AChRs expressed in permanently transfected HEK cells.

Nelson ME, Wang F, Kuryatov A, Choi CH, Gerzanich V, Lindstrom J. Nelson ME, et al. Among authors: gerzanich v. J Gen Physiol. 2001 Nov;118(5):563-82. doi: 10.1085/jgp.118.5.563. J Gen Physiol. 2001. PMID: 11696612 Free PMC article.

4

Chronic nicotine alters NO signaling of Ca(2+) channels in cerebral arterioles.

Gerzanich V, Zhang F, West GA, Simard JM. Gerzanich V, et al. Circ Res. 2001 Feb 16;88(3):359-65. doi: 10.1161/01.res.88.3.359. Circ Res. 2001. PMID: 11179206

5

Mislocalization of eNOS and upregulation of cerebral vascular Ca2+ channel activity in angiotensin-hypertension.

Gerzanich V, Ivanova S, Zhou H, Simard JM. Gerzanich V, et al. Hypertension. 2003 May;41(5):1124-30. doi: 10.1161/01.HYP.0000066288.20169.21. Epub 2003 Mar 31. Hypertension. 2003. PMID: 12668586

6

Chlorotoxin-sensitive Ca2+-activated Cl- channel in type R2 reactive astrocytes from adult rat brain.

Dalton S, Gerzanich V, Chen M, Dong Y, Shuba Y, Simard JM. Dalton S, et al. Among authors: gerzanich v. Glia. 2003 Jun;42(4):325-39. doi: 10.1002/glia.10212. Glia. 2003. PMID: 12730953

7

Adenosine-A2a receptor down-regulates cerebral smooth muscle L-type Ca2+ channel activity via protein tyrosine phosphatase, not cAMP-dependent protein kinase.

Murphy K, Gerzanich V, Zhou H, Ivanova S, Dong Y, Hoffman G, West GA, Winn HR, Simard JM. Murphy K, et al. Among authors: gerzanich v. Mol Pharmacol. 2003 Sep;64(3):640-9. doi: 10.1124/mol.64.3.640. Mol Pharmacol. 2003. PMID: 12920200

8

Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury in vivo.

Gerzanich V, Ivanova S, van der Heijden MS, Zhou H, Simard JM. Gerzanich V, et al. Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):2048-54. doi: 10.1161/01.ATV.0000094962.07514.BC. Epub 2003 Sep 11. Arterioscler Thromb Vasc Biol. 2003. PMID: 12969989

9

Alternative splicing of cGMP-dependent protein kinase I in angiotensin-hypertension: novel mechanism for nitrate tolerance in vascular smooth muscle.

Gerzanich V, Ivanov A, Ivanova S, Yang JB, Zhou H, Dong Y, Simard JM. Gerzanich V, et al. Circ Res. 2003 Oct 31;93(9):805-12. doi: 10.1161/01.RES.0000097872.69043.A0. Epub 2003 Sep 25. Circ Res. 2003. PMID: 14512447

10

Early pathophysiological changes in cerebral vessels predisposing to stroke.

Gerzanich V, Ivanova S, Simard JM. Gerzanich V, et al. Clin Hemorheol Microcirc. 2003;29(3-4):291-4. Clin Hemorheol Microcirc. 2003. PMID: 14724353

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters